- Home
- ISTR vs LYEL Comparison
ISTR vs LYEL Comparison
Compare ISTR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- LYEL
- Stock Information
- Founded
- ISTR 2006
- LYEL 2018
- Country
- ISTR United States
- LYEL United States
- Employees
- ISTR N/A
- LYEL N/A
- Industry
- ISTR Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- LYEL Health Care
- Exchange
- ISTR Nasdaq
- LYEL Nasdaq
- Market Cap
- ISTR 225.1M
- LYEL 253.2M
- IPO Year
- ISTR 2014
- LYEL 2021
- Fundamental
- Price
- ISTR $23.84
- LYEL $16.98
- Analyst Decision
- ISTR Buy
- LYEL Buy
- Analyst Count
- ISTR 1
- LYEL 2
- Target Price
- ISTR $29.00
- LYEL $15.00
- AVG Volume (30 Days)
- ISTR 43.7K
- LYEL 27.4K
- Earning Date
- ISTR 10-20-2025
- LYEL 11-12-2025
- Dividend Yield
- ISTR 1.84%
- LYEL N/A
- EPS Growth
- ISTR 24.14
- LYEL N/A
- EPS
- ISTR 2.22
- LYEL N/A
- Revenue
- ISTR $93,426,000.00
- LYEL $60,000.00
- Revenue This Year
- ISTR $7.24
- LYEL N/A
- Revenue Next Year
- ISTR $70.19
- LYEL N/A
- P/E Ratio
- ISTR $10.76
- LYEL N/A
- Revenue Growth
- ISTR 12.93
- LYEL 11.11
- 52 Week Low
- ISTR $15.39
- LYEL $7.65
- 52 Week High
- ISTR $25.71
- LYEL $24.00
- Technical
- Relative Strength Index (RSI)
- ISTR 57.08
- LYEL 52.23
- Support Level
- ISTR $23.62
- LYEL $16.08
- Resistance Level
- ISTR $24.25
- LYEL $18.60
- Average True Range (ATR)
- ISTR 0.59
- LYEL 1.25
- MACD
- ISTR -0.01
- LYEL -0.08
- Stochastic Oscillator
- ISTR 37.89
- LYEL 43.64
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.